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BACKGROUND & AIMS: The transcription factor atonal homo-
log 1 (ATOH1) controls the fate of intestinal progenitors down-
stream of the Notch signaling pathway. Intestinal progenitors
that escape Notch activation express high levels of ATOH1 and
commit to a secretory lineage fate, implicating ATOH1 as a
gatekeeper for differentiation of intestinal epithelial cells.
Although some transcription factors downstream of ATOH1,
such as SPDEF, have been identiﬁed to specify differentiation and
maturation of speciﬁc cell types, the bona ﬁde transcriptional
targets of ATOH1 still largely are unknown. Here, we aimed to
identify ATOH1 targets and to identify transcription factors that
are likely to co-regulate gene expression with ATOH1.
METHODS: We used a combination of chromatin immunopre-
cipitation and messenger RNA–based high-throughput
sequencing (ChIP-seq and RNA-seq), together with cell sorting
and transgenic mice, to identify direct targets of ATOH1, and
establish the epistatic relationship between ATOH1 and SPDEF.
RESULTS: By using unbiased genome-wide approaches, we
identiﬁed more than 700 genes as ATOH1 transcriptional
targets in adult small intestine and colon. Ontology analysis
indicated that ATOH1 directly regulates genes involved in
speciﬁcation and function of secretory cells. De novo motif
analysis of ATOH1 targets identiﬁed SPDEF as a putative
transcriptional co-regulator of ATOH1. Functional epistasis
experiments in transgenic mice show that SPDEF ampliﬁes
ATOH1-dependent transcription but cannot independently
initiate transcription of ATOH1 target genes.
CONCLUSIONS: This study unveils the direct targets of ATOH1
in the adult intestines and illuminates the transcriptional
events that initiate the speciﬁcation and function of intestinal
secretory lineages. (Cell Mol Gastroenterol Hepatol 2016;-:-–-;
http://dx.doi.org/10.1016/j.jcmgh.2016.10.001)
Keywords: ATOH1; SPDEF; Transcription; Intestinal Epithelium;
Villin-creER; TRE-Spdef; Atoh1GFP; Atoh1Flag.FLA 5.4.0 DTD  JCMGH172 proof  5Qhe adult intestinal epithelium proliferates rapidly
QQTwith average cellular lifespans of approximately 5–7
days. To maintain epithelial integrity and perform its major
function of nutrient digestion and absorption, intestinal
stem cells (ISCs) located at the base of crypts of Lieberkühn
must self-renew and produce transit-amplifying cells, which
subsequently differentiate into 1 of 2 cell classes: absorptive
lineage cells, including enterocytes and colonocytes; and
secretory lineage cells, including mucus-secreting goblet
cells, hormone-secreting enteroendocrine cells, and antimi-
crobial peptide-secreting Paneth cells.1–3 Under physiolog-
ical conditions, signaling pathways, such as Notch and Wnt,
modulate homeostasis and differentiation of the intestinal
epithelium, directing ISCs/progenitors toward either the
absorptive or secretory fate by controlling the expression of
a downstream transcriptional network.4,5 Dysregulated ISC
proliferation or aberrant differentiation may cause gastro-
intestinal diseases, such as inﬂammatory bowel disease and
intestinal cancer.5,6
Canonical Notch signaling relies on direct cell–cell con-
tact and plays an important role in modulating homeostasis
and differentiation of the intestinal epithelium. In the
intestines, Notch signaling controls the fate of ISCs/
progenitors by regulating the expression of the basic helix-
loop-helix transcription factor atonal homolog 1 (ATOH1).5
Previous studies have suggested that ATOH1 is required
for the differentiation of all secretory cells.7 Germ-line Atoh1





























































































































2 Lo et al Cellular and Molecular Gastroenterology and Hepatology Vol. -, No. -form any secretory cells without affecting enterocytes.7
Consistent with these observations, conditional deletion of
Atoh1 in the adult intestinal epithelium results in the loss of
all secretory cells.8 In contrast, overexpression of ATOH1
directs progenitor cells to the secretory cell fate in the
embryonic intestine.9 Previous studies have indicated
that pharmacologic inhibition of Notch signaling using
g-secretase inhibitors or speciﬁc antibodies blocking the
Notch receptors results in loss of proliferative progenitor
cells and secretory cell hyperplasia.10–12 However, Atoh1-
deﬁcient intestines fail to respond to Notch inhibition, indi-
cating that the primary role of Notch is to regulate the
expression of Atoh1, and in doing so control secretory vs
absorptive cells fate.13–15 Consistent with the concept, a
recent study suggested that ATOH1 controls Notch-
medicated lateral inhibition in the adult intestinal epithe-
lium.16 These results indicate that ATOH1 is a critical gate-
keeper for the program of Notch-mediated differentiation
and cell fate determination of intestinal epithelial cells.
Although previous studies have suggested that some tran-
scription factors, such as SAM pointed domain containing
ETS transcription factor (Spdef) and growth factor indepen-
dent 1 (Gﬁ1), are downstream of ATOH1 and are important
for differentiation of speciﬁc secretory cell types,17–19 the
bona ﬁde targets of endogenous ATOH1 at the genome-wide
level in the adult intestine still largely are unknown.
To better understand the molecular functions of ATOH1
in vivo, we used a combination of chromatin immunopre-
cipitation (ChIP) and RNA-based, high-throughput
sequencing techniques to identify direct transcriptional
targets of ATOH1 in ileal and colonic crypts. In addition, our
data unveiled a novel molecular mechanism whereby SPDEF
functions as a transcriptional co-regulator of ATOH1,
amplifying ATOH1-dependent transcription of a subset of
secretory genes. This study provides novel insight toward
understanding cell fate decisions within the intestines.
Materials and Methods
Animals
VilCreERT2; Fabp1Cre; Atoh1ﬂ/ﬂ; Rosa26 LSL-rtta-ires-EGFP;
TRE-Spdef; Spdef null; Atoh1GFP/GFP; and Atoh1Flag/Flag mice
have been described previously.8,18,20–24 To achieve deletion
of Atoh1 from intestinal epithelium, Atoh1ﬂ/ﬂ; VilCreERT2
mice and littermate controls were given an intraperitoneal
injection of 1 mg/mouse tamoxifen (Sigma) dissolved in
corn oil for 3 consecutive days. Animals were killed 5 days
after the ﬁrst injection. To achieve SPDEF induction,
Fabp1Cre; Atoh1ﬂ/ﬂ; Rosa26 LSL-rtta-ires-EGFP; TRE-Spdef mice,
and littermate controls were given 2 mg/mL tetracycline in
water for 5 consecutive days. To achieve Notch inhibition,
mice were treated either with vehicle or GSI-20 (also called
dibenzazepine [DBZ]; EMD–Calbiochem) at 15 mmol/L/kg
once a day for 5 days. All mouse studies were approved by
the Institutional Animal Care and Use Committee.
Crypt Isolation
Intestinal crypts were prepared as previously
described.25 Entire colons and 6–7 cm distal small intestineFLA 5.4.0 DTD  JCMGH172 proof  5were dissected out and ﬂushed with ice-cold phosphate-
buffered saline (PBS) with 5 mmol/L phenylmethylsulfonyl
ﬂuoride. Intestines were opened lengthwise and cut into
1-cm pieces. Tissues were incubated with shaking buffer
(25 mmol/L EDTA, protease inhibitor cocktail; Calbiochem)
at 4C for 30 minutes by gentle shaking. Shaking buffer was
replaced by ice-cold Ca2þ/Mg2þ-free Dulbecco’s PBS fol-
lowed by vigorous shaking for approximately 8–10 minutes
to generate disassociated crypts. For the colon, it takes
15 minutes to disassociate crypts. Intestinal crypts were
isolated by ﬁltering through a 70-mm cell strainer (BD Q
Falcon) for small intestinal crypts and a 100-mm cell
strainer (BD Falcon) for colonic crypts, and then spun down
at 150g for 10 minutes.
Cell Culture
Human colorectal cancer cell line HCT116 was grown in
RPMI1640 (10-040-CV; Corning Q) supplemented with 10%
fetal bovine serum (S1200-500; BioExpress), penicillin, and
streptomycin (17-602E; Lonza).
Plasmids and DNA Transfection
Expression plasmid of ATOH1-GFP Qwas a gift from
Dr Tiemo Klisch (Baylor College of Medicine).20 HCT116
cells were transfected by using Lipofectamine 2000 (11668-
019; Invitrogen Q) following the manufacturer’s instructions.
ChIP
Crypts and transfected cells were used in ChIP experi-
ments with antibodies against GFP (NB600-303; Novus Q),
Flag M2 (F1804; Sigma), H3k27Ac (ab4729; Abcam), or
H3K27me3 (ab6002; Abcam). For each ChIP sample, 2–3 mg
of antibodies were used to bind to 10 mL Protein G Dyna-
beads (100-03D; Invitrogen) following the manufacturer’s
instructions. Samples from either crypts or 5–10  106
HCT116 cells transfected with ATOH1-GFP were cross-
linked in 1% formaldehyde (15710; Electron Microscopy
Sciences) in cross-linking buffer (50 mmol/L HEPES pH 8.0,
1 mmol/L EDTA pH 8.0, 1 mmol/L ethylene glycol-bis
[b-aminoethyl ether]-N,N,N0,N0-tetraacetic acid pH 8.0, 100
mmol/L NaCl, RPMI1640) at room temperature for 30
minutes and then quenched by adding glycine to a ﬁnal
concentration of 135 mmol/L on ice for 5 minutes. Cross-
linked cells were washed twice with ice-cold PBS and
stored at -80C before sonication. Chromatin was sheared to
300- to 1000-bp fragments in 1 mL ice-cold sonication
buffer (10 mmol/L Tris-HCl pH 8.0, 1 mmol/L EDTA pH 8.0,
1 mmol/L ethylene glycol-bis[b-aminoethyl ether]-N,N,N0,N0-
tetraacetic acid pH 8.0, supplemented with a protease in-
hibitor cocktail; 539134; Calbiochem), using a 250D Soniﬁer
Ultrasonic Processor Cell Disruptor (Branson) with a one-
eighth inch microtip (50% power output, interval 1-
second on/1-second off, for a total of 24 minutes). Sarko-
syl was added to a ﬁnal concentration of 0.5% and the
sheared chromatin was incubated at room temperature for
10 minutes and then spun down to remove debris. For
immunoprecipitation, 500 mL sheared chromatin was mixed

















































































309sodium deoxycholate, 4.4% Triton X-100) and incubated
with 10 mL antibody-bound protein G Dynabeads at 4C
overnight. ChIP samples were washed in washing buffer
(1% Nonidet P-40, 1% sodium deoxycholate, 1 mmol/L
EDTA pH 8.0, 50 mmol/L HEPES pH 8.0, 500 mmol/L LiCl)
5 times and then eluted in elution buffer (50 mmol/L
Tris-HCl pH 8.0, 10 mmol/L EDTA pH 8.0, 1% sodium
dodecyl sulfate) at 65C for 15 minutes. Both ChIP and input
samples were incubated at 65C overnight to reverse
formaldehyde cross-linking. DNA was puriﬁed by phenol-
chloroform extraction. Precipitated DNA fragments were
used for ChIP sequencing (ChIP-seq) or polymerase chain
reaction (PCR). The ChIP-seq library was made following the
instructions of the NEBNext ChIP-Seq Library Prep Master
Mix Set (E6240; New England Biolabs). The primers used














Sorted ATOH1-GFP–positive cells and puriﬁed crypts
from either Atoh1 deletion or littermate control mice were
collected immediately in TRIzol reagent (Invitrogen). RNA
was isolated following the manufacture’s instructions and
subsequently puriﬁed with the RNeasy kit (Qiagen), using
on-column DNAse digestion (Qiagen). RNA quality controls
were performed by the Gene Expression Core at Cincinnati
Children’s Hospital Medical Center using an Agilent
Bioanalyzer nanochip. The RNA integrity number of the RNA







330Reverse-Transcription and Real-Time PCR
A total of 1 mg RNA was used to synthesize comple-
mentary DNA using Superscript III First Strand Synthesis
System (Invitrogen) following the manufacturer’s
instructions. Quantitative PCR was performed with Brilliant
III Ultra Fast SYBR Green Master Mix (Agilent Technologies)

























Intestinal tissues were ﬁxed in 4% paraformaldehyde in
PBS at 4C overnight, transferred to 70% ethanol, parafﬁn-
embedded, and sectioned at 5-mm thickness. Parafﬁn-
embedded sections were deparafﬁnized and rehydrated
before staining. For immunoﬂuorescence, antigen retrieval
was achieved in sodium citrate buffer (10 mmol/L sodium
citrate pH 6.0). The sections were blocked in 4% normal
donkey serum in PBS at room temperature for 1 hour.
Primary antibodies against GFP (1:1000; Abcam) and
chromagranin A (1:5000; Immuostar), mucin 2 (1:1000;
Santa Cruz), or lysozyme (1:5000; Zymed Laboratories)
were co-incubated on the sections in blocking buffer (4%
normal donkey serum in PBS) at 4C overnight. After
washing 3 times by PBS, donkey anti-goat–Alexa 488 and
donkey anti-rabbit–Alexa 594 secondary antibodies (1:200;
Invitrogen) were incubated on the sections at room tem-
perature for 1 hour. All sections were washed 3 times by
PBS and mounted with Vectashield medium with 40,6-
diamidino-2-phenylindole (Vector).FLA 5.4.0 DTD  JCMGH172 proof  5In Situ Hybridization
Fresh intestinal tissues were harvested from mice and
lightly ﬁxed by 4% paraformaldehyde on ice for 15 minutes.
Fixed tissues were cryoprotected with 30% sucrose in PBS
and then embedded in ornithine carbamyl transferase Q.
In situ hybridization staining was performed as previously
described.26 In situ hybridization staining was performed by
the RNA In Situ Hybridization Core at Baylor College of
Medicine.
Fluorescence-Activated Cell Sorting
Isolated crypts were dissociated as previously
described.25 Brieﬂy, crypts were dissociated with TrypLE
express (Invitrogen) supplemented with 10 mmol/L
Y-27632 and 1 mmol/L N-acetylcysteine (Sigma-Aldrich) for
5 minutes at 37C. Cell clumps were removed using a 35-mm
cell strainer (Fisher QScientiﬁc) and the ﬂow-through was
pelleted at 500  g at 4C for 5 minutes. Cell pellets were
resuspended in 5% bovine serum albumin, 1 mmol/L EDTA,
and 10 mmol/L Y27632 (Sigma-Aldrich) in PBS at 2–5  106
cells/mL. 7-AAD was added 20 minutes before ﬂuorescence-
activated cell sorting (FACS) to evaluate cell viability.
A FACSAria II equipped with a 100-mm nozzle was used (BD
Biosciences). GFP-positive and 7-AAD–negative single cells
were sorted into 500 mL TRIzol reagent (Invitrogen) for
RNA sequencing.
RNA-Seq Data Preprocessing and Analysis
Total RNA from 14 samples from mouse colon and ileum
(2 biological replicates of wild-type and Atoh1-mutant
crypts, 3 biological replicates of GFPþ cells) were prepared
for RNA sequencing using the Illumina HiSeq 2000 with
single-end, 50-bp reads (Illumina, San Diego, CA). For each
sample, 14–23 million of 50-bp, single-end reads were
generated. The raw reads were aligned to the Mus musculus
genome (Ensembl mm9) using TopHat v1.4.1 (http://tophat.
cbcb.umd.edu/) with default parameters (-r 400 –p -8 Q).27
The mappability for each sample was greater than 80%.
To measure the expression level from aligned sequence
reads for differential gene analysis, we used the free Python Q
program HTSeq.28 The htseq-count function of HTSeq
allowed us to quantify the number of aligned reads that
align with the exons of the gene (union of all the exons of
the gene). The read counts obtained were analogous to the
expression level of the gene. By using the raw counts,
differential gene analysis was performed using the DESeq
package in the R environment. DESeq includes functions to
test for gene expression changes between samples in
different conditions by the use of the negative binomial
distribution and a shrinkage estimator for the distribution’s
variance.29 The nbinomTest function of DESeq was used to
test if each gene was expressed differentially. The signiﬁ-
cance of the observed changes are indicated by the P value,
and the false-discovery rate (FDR) reported in the article Q
is the P values adjusted for multiple testing with the
Benjamini–Hochberg procedure implemented within DESeq.
Heatmaps of gene expressions were plotted using the



















































































































































































































































576ChIP-Seq Data Preprocessing and Analysis
ChIP samples from mouse colon and ileum were
sequenced using an Illumina HiSeq 2000. Fourteen samples
were prepared: H3k27me3, H3k27Ac, 2 replicates of
ATOH1-GFP, and 3 replicates of input for each tissue. Each
sample was sequenced at a depth of 9–18 million, 50-bp,
single-end reads. Reads were trimmed from both ends
before mapping to the reference genome. The trimmed
reads were ﬁrst mapped to the Mus musculus genome
(Ensembl mm9) using Bowtie2 with the preset of the very-
sensitive setting (speciﬁc parameters are as follows: -D 20
-R 3 -N 0 -L 20 -i S,1,0.50).30 The mappability for each
sample was greater than 75% except for the GFP samples.
By using the mapping ﬁles, regions with enriched ATOH1
binding were identiﬁed using well-established, peak-calling
software, MACs.31 The input samples were used as the
control for calling peaks from the ATOH1, histone methyl-
ation, or histone acetylation data sets. Peaks (ATOH1 and
histone-bound regions) then were annotated with Homer
using the mouse mm9 gene model.32 In the binding site
comparison analysis (Figure 3B), we used deeptools to
generate peak-based correlation heatmaps and scatter-
plots.33 ATOH1 ChIP-Seq data from the cerebellum were
obtained from GEO DataSets (GSE22111). First, all aligned
ChIP-seq data in bam format were ratio-normalized to their
respective inputs and converted to bigwig format using the
bamCompare module from deeptools. Next, the whole
genome was binned into 10-kb windows and respective
coverage was computed across the 3 different tissues
(ileum, colon, and cerebellum), using the computeMatrix
module of deeptools. PlotCorrelation was used to compute
genome level correlations and to generate scatterplots.
To directly compare ileal vs colonic ATOH1 binding sites
(Figure 3C), log2-normalized enrichment of binding regions
were plotted on both axes, which was deﬁned using the
following formula. This is analogous to the average peak
height (RPM) analyzed as described previously.34
log2

Atoh1 normalized peak height
Input normalized peak height

ATOH1 De Novo Motif Analysis
The hypergeometric optimization of motif enrichment
(HOMER) software suite was used to identify DNA motifs
enriched in the ChIP-seq data sets. First, sites bound by
ATOH1 (Figure 3A) were subjected to de novo motifFigure 1. (See previous page). ATOH1 is required for all secr
combined with Alcian blue (AB) and periodic acid–Schiff (PA
Atoh1GFP/GFP indicates that endogenous ATOH1 is expressed
ﬂuorescent analysis of ileum and colon from Atoh1GFP/GFP mice i
lineages. Goblet cells were labeled by mucin 2 (MUC2). Paneth c
were labeled by chromogranin A (CHGA). (C) Immunoﬂuorescen
enteroendocrine (EE) cells compared with goblet and Paneth ce
the intestinal epithelium was achieved by using Atoh1lox/lox;VilC
Alcian blue staining showed that the secretory lineages were
wild-type control Atoh1lox/WT;VilCreERT2 mice. Scale bars: 100 m
wild type.
FLA 5.4.0 DTD  JCMGH172 proof  5identiﬁcation using ﬁndMotifsGenome.pl within HOMER.
Second, de novo motif identiﬁcation was performed on
ATOH1 binding sites within the colon ATOH1 targetome
(Figure 5A Q). Signiﬁcantly enriched motifs were matched to
the most similar transcription factor–binding motifs from
the JASPAR Q2014 database. FIMO was used to retrieve genes
with SPDEF binding motifs from the ATOH1 targetome.Gene Ontology Analysis
Gene ontology (GO) analysis was performed with
Database for Annotation, Visualization, and Integrated
Discovery (DAVID; available: http://david.abcc.ncifcrf.gov/)
using the ATOH1 targetome genes lists (Figure 5) to identify
the biological processes and molecular functions in which
the input gene lists are enriched. The -log10(FDR) of the
enriched functions were plotted to indicate the signiﬁcance
of the enrichment of each function.
Results
ATOH1 Transcriptional Proﬁle in the Adult
Distal Small Intestinal and Colon Crypts
Previous studies have shown that ATOH1 is required
for the differentiation of secretory cell lineages in the
intestines.7 Conditional deletion of Atoh1 in the adult
intestine conﬁrmed that ATOH1 is expressed in and
essential for the formation of all secretory cells.8 Consis-
tent with these observations, Alcian blue and periodic
acid–Schiff staining indicated that mice with an
ATOH1–GFP fusion protein inserted into the Atoh1 locus
(Atoh1GFP/GFP) express ATOH1–GFP in goblet and Paneth
cells (Figure 1A). Speciﬁcally, ATOH1–GFP expression is
co-localized with all secretory cells, including mucin
2–positive goblet cells, lysozyme 1–positive Paneth cells, as
well as chromogranin A–positive enteroendocrine cells
(Figure 1B and C).35
To deﬁne ATOH1-associated transcripts in adult in-
testines, we ﬁrst generated 3 messenger RNA (mRNA)
expression proﬁles by RNA-seq of the following: (1) wild-
type crypts, (2) Atoh1 deletion crypts, and (3) puriﬁed
ATOH1-positive cells. We isolated Atoh1 deletion and
littermate wild-type crypts from 6- to 8-week old Atoh1lox/
lox;VilCreERT2 and Atoh1lox/WT;VilCreERT2 mice, respectively.
After tamoxifen injection for 3 consecutive days, secretory
lineages were nearly absent throughout the entire intestinal
epithelium (Figure 1D). ATOH1-positive cells were isolatedetory lineages in ileum and colon. (A) Immunohistochemistry
S) staining of the ileum and colon from transgenic mice
in goblet and Paneth cells. Scale bars: 100 mm. (B) Immuno-
ndicates that endogenous ATOH1 is expressed in all secretory
ells were labeled by lysozyme 1 (LYZ1). Enteroendocrine cells
ce analysis indicates the expression level of ATOH1 is lower in
lls in Atoh1GFP/GFP mice. (D) Conditional deletion of ATOH1 in
reERT2 mice. After tamoxifen injection for 3 consecutive days,
nearly absent in both the ileum and colon compared with




























































































































































































































































813by ﬂow cytometry of 7AAD-negative (live), GFP-positive
cells from either ileal or colonic crypts of Atoh1GFP/GFP
mice (Figure 2A). RNA sequencing was performed on the
Illumina Hi-Seq 2000 with single-end, 50-bp reads. Three
puriﬁed ATOH1–GFP–positive, 2 Atoh1 wild-type, and 2
Atoh1 deletion samples were collected from the ileum and
colon of independent animals with corresponding genotypes
(total, 14 samples). By using hierarchal clustering analysis,
we observed that samples generated from independent
experiments for each group clustered together, indicating
that the RNA-seq data were highly reproducible and reliable
(Figure 2B). To evaluate whether these RNA-seq data
represent a secretory cell–associated gene signature, we
assessed the expression of genes characteristic of individual
cell types in the intestine. We selected 71 genes repre-
senting 5 different intestinal cell types, and created a heat
map of gene expression from our RNA-seq data sets
(Figure 2C). As expected, compared with wild-type crypts,
the expression of goblet and Paneth cell genes was enriched
in puriﬁed ATOH1-positive cells, but decreased in Atoh1
deletion crypts (Figure 2C). Of note, compared with
wild-type crypts, we did not observe signiﬁcant enrichment
of enteroendocrine genes in isolated ATOH1-positive cells.
However, the expression of enteroendocrine genes was
decreased in Atoh1 deletion crypts, indicating that although
enteroendocrine cells require ATOH1 for their formation,
they were not efﬁciently puriﬁed during FACS of
ATOH1–GFP cells, likely owing to their low level of
ATOH1–GFP (Figure 1C). As expected, ATOH1-positive
cells expressed lower absorptive enterocyte/colonocyte
and intestinal stem cell genes (Figure 2C). Finally, to identify
genes that are regulated by ATOH1, we compared these
3 expression groups with each other and identiﬁed
genes with at least a 1.5-fold difference in expression level
with an adjusted P value less than .05. We identiﬁed 2322
genes in the colon and 2364 genes in the ileum that were
enriched in ATOH1-positive cells (Figure 2D, Supplementary
Table 3). Hierarchal clustering analysis for the intersection
area (68 genes in the ileum and 84 genes in the colon
enriched in ATOH1-expressing cells) veriﬁed the sample-to-
sample reproducibility of the transcripts we identiﬁed
(Figure 2E, Supplementary Table 4). On the other hand, we
identiﬁed 3187 genes in the colon and 3099 genes in the
ileum that were expressed at a lower level in
ATOH1–GFP–positive cells (Figure 2F, Supplementary
Table 5). Taken together, we generated ATOH1-associated
transcripts in adult small and large intestines under
homeostatic conditions.Figure 2. (See previous page). Transcriptional proﬁle of ATOH
ﬂow cytometry from either ileal or colonic crypts of Atoh1GFP
independent RNA-seq samples generated from ATOH1-positiv
Numbers in the ﬁgure indicate Pearson correlation coefﬁcients. (
in the intestine. (D) Venn diagram indicates overlap of genes th
(E) Heat map of mRNA expression of genes we identiﬁed shows
and colon. (F) Venn diagram indicates overlap of genes that ar
knockout; PE-A, ____________; WT, wild type
FLA 5.4.0 DTD  JCMGH172 proof  5ATOH1 Genomic Binding Sites in Adult
Ileal and Colonic Crypts
To identify targets of ATOH1 binding in the adult intestinal
epithelium, we performed chromatin immunoprecipitation-
sequencing (ChIP-seq). Ileal or colonic crypts were isolated
from 10- to 12-week-old adult Atoh1GFP/GFP mice (which
express a functional ATOH1::GFP Qprotein and are phenotypi-
cally normal35) followedbyATOH1,H3K27Ac, andH3K27me3
ChIP-Seq. We prepared duplicate ATOH1 ChIP-seq libraries
from 2 independent experiments for both tissues. Analysis of
pooled data identiﬁed 2008 ATOH1 binding sites in the ileum
and 9219 ATOH1 binding sites in the colon (FDR < 1e-10 Q)
across the entire genome (Figure 3A, Supplementary Tables 6
and 7). Next, we performedQ enrichment score (QES) analysis
to verify the quality of these ATOH1 binding sites.36 Compared
with the reference values for the quality metrics generated
from 392 data sets from ENCODE Q, the QES from our ATOH1
ChIP-seq (QES, 0.24 in colon;QES, 0.16 in ileum)was ranked at
a level between moderate high to very high (http://charite.
github.io/Q/tutorial.html#output_of_q), suggesting a high
quality of these ATOH1 peaks (Supplementary Table 8).
To study the ATOH1 binding patterns between tissues, we
ﬁrst assessed the co-occurrence of all ATOH1 binding sites in
the ileum and colon; for comparison, we included ATOH1
ChIP-seq results from the developing cerebellum20 in this
analysis (Figure 3B). Our results showed that ATOH1 binding
sites were similar between the ileum and colon (Spearman
correlation coefﬁcient, 0.42) as compared with cerebellum
(correlation coefﬁcient, 0.06–0.08). Next, we restricted our
comparison with sites that were enriched signiﬁcantly in
either ileum or colon (shown in Figure 3A), which showed
stronger correlation of co-occurring ATOH1 binding sites
(Figure3C). Althougha fair portion of theATOH1-boundpeaks
called from colon were not considered signiﬁcant peaks in
ileum (Figure 3C, redpoints), the enrichmentswere correlated
highly (ie aligned with the x ¼ y line, shown as a dotted line),
indicating strong enrichment for ATOH1 at similar sites in the
small intestine and colon. For each tissue, the distribution of
peaks across functional domains in the genome was analyzed
(Figure 3A). ATOH1 peaks were enriched strongly in gene-
associated functional domains, such as promoter (by default
deﬁned from -1 kb to þ100 bp of transcription start site
[TSS]), untranslated region, intron, and exon, where they
usually mapped within 1 kb of the TSS, indicating that the
peaks generated from our ATOH1 ChIP-seq were not located
randomly on the genome but instead were associated with
core promoters (Figure 3E). Consistent with its predicted
activity as a transcription activator, ATOH1 binding sites were1-positive cells. (A) Live ATOH1-positive cells were sorted by
/GFP mice for RNA-seq. (B) Hierarchal clustering analysis of
e cell sorting, wild-type crypts, and Atoh1 deletion crypts.
C) Heat map of gene expression of individual cell type markers
at are enriched signiﬁcantly at least 1.5-fold in each group.
a signiﬁcant enrichment in ATOH1-positive cells in the ileum
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1013highly co-localizedwith active enhancermarkerH3K27Ac, but
not inactive chromatin-associated H3K27me3 (Figure 3D).
Because we aimed to identify ATOH1 direct transcriptional
targets, we deﬁned genes that have ATOH1 binding sites
within 20 kb of the TSS as ATOH1-associated genes. We
identiﬁed 1024 and 4876 ATOH1-associated genes in ileum
and colon, respectively (Figure 3F). Based on initial overlap
analysis, 92.7% (949 of 1024 genes) of ATOH1-associated
genes in the ileum also were bound by ATOH1 in the colon
(Figure 3F). Taken together, using ChIP-seq, we identiﬁed






























1043Motif Analysis of ATOH1 Binding Regions
Previous studies in the developing cerebellum have
indicated that ATOH1 binds to a 10-nucleotide motif
(AtEAM) containing a consensus E-box (5’-CANNTG-3’)
binding motif of basic helix-loop-helix transcription fac-
tors.20 We performed de novo motif analysis for our ATOH1
ChIP-seq data using HOMER.32 As expected ATOH1-bound
chromatin was enriched signiﬁcantly in consensus E-box
motifs in both colon and ileum (P ¼ 1e-96 in ileum and
1e-722 in colon) (Figure 3G). This indicated that direct
binding sites of ATOH1 were enriched in our ChIP-seq data.
In addition to E-box, additional DNA binding motifs for
several other transcription factor classes were enriched
signiﬁcantly within ATOH1-bound chromatin (Figure 3G).
According to our RNA-seq data, we identiﬁed several tran-
scription factors that were highly expressed within
ATOH1–GFP–puriﬁed cells, and whose consensus DNA
binding motif matched to these binding sequences derived
de novo from ATOH1 ChIP-seq analysis (Figure 3G).
Included in this list of transcription factors are E2A, HEB,
RUNX1, YY1, NFIC, and HLTF, suggesting that these factors
may bind cooperatively with ATOH1 to regulate secretory
cell transcription. In fact, E2A and HEB are class I basic
helix-loop-helix proteins known to interact with ATOH1,37
suggesting that these are its relevant partners within the
intestine. Taken together, these results show that our
ATOH1 ChIP-seq comprehensively identiﬁed ATOH1 targets
in small and large intestines.1044
1045
1046
1047Validation of ATOH1 Binding Sites
To validate our ATOH1 ChIP-seq data, we performed
ChIP PCR in a different transgenic mouse model, which hasFigure 3. (See previous page). ATOH1 genomic binding regi
ChIP-seq peaks. (B) Comparison of colonic ATOH1, H3K27Ac
counts in the 40 kb surrounding ATOH1 peaks. (C) Genome-wid
and cerebellum. Scatterplots show the distribution of enrichmen
Numbers in the ﬁgure indicate Spearman correlation coefﬁcien
signiﬁcant enrichment in ATOH1-bound chromatin from either
peaks from both the ileum and colon, red points are signiﬁca
signiﬁcant peaks from the ileum only. (E) Distribution of ATOH1 C
that have ATOH1 binding sites within 20 kb of the TSS are d
overlap of ATOH1-associated genes in the ileum and colon. (G)
identiﬁed by HOMER de novo motif analysis. P values are for m
were listed. TFs, _____________.
FLA 5.4.0 DTD  JCMGH172 proof  5an ATOH1–Flag fusion protein inserted into the Atoh1 locus
(Atoh1Flag/Flag).38 We ﬁrst focused on the ATOH1-associated
genes Sox9, Gﬁ1, and Spdef, which have been implicated in
secretory lineage differentiation. The HMG Q-box transcription
factor SOX9 is expressed in the epithelial cells of the intes-
tinal crypts and is required for goblet and Paneth cell
differentiation.39,40 Previous studies have suggested that
both the zinc-ﬁnger transcription factor Gﬁ1 and the
Ets-transcription factor SPDEF are downstream targets of
ATOH1.17,19 GFI1 directs secretory progenitors toward a
goblet or Paneth cell fate, in part by repression of the pro-
endocrine transcription factor NEUROG3.41 SPDEF plays
an important role in goblet and Paneth cell terminal dif-
ferentiation in the intestines.17,18 Our ATOH1 ChIP-seq data
indicated that ATOH1 binds to the core promoter regions of
Sox9, Gﬁ1, and Spdef (Figure 4A). Consistent with our ChIP-
seq results, we conﬁrmed by ChIP PCR that ATOH1–Flag
was enriched at the promoters of these target genes, but not
upstream negative control regions (Figure 4B). Next, to
conﬁrm our ATOH1 ChIP-seq data further, we selected
another 8 ATOH1-associated genes for validation. All 8
ATOH1 binding regions were validated by ChIP PCR,
including Neurog3, Dll4, Tff3, Creb3l1, Galnt12, Bcas1, Foxa1,
and Cbfa2t3 (Figure 4B). Taken together, these results
conﬁrm that ATOH1 binding sites identiﬁed by our ChIP-seq
analysis were robust and highly reliable.
Identifying ATOH1 Transcriptional Targets
To identify direct ATOH1 transcriptional targets in the
intestines, we compared ATOH1-associated genes identiﬁed
by our ATOH1 ChIP-seq analysis (Figure 3F) with
up-regulated genes in ATOH1-positive cells identiﬁed by our
RNA-seq analysis (Figure 2D). We deﬁned the ATOH1
targetome as the 658 genes in the colon and 193 genes in
the ileum with signiﬁcantly enriched expression in ATOH1-
positive cells that also were bound by ATOH1 (Figure 5A,
Supplementary Table 9). Consistent with the concept that
ATOH1 functions as a key transcription factor for differen-
tiation of the intestinal epithelium, several ATOH1 target
genes were known to be involved in intestinal secretory
lineage differentiation and function, such as Notch ligands
Dll1 and Dll4; transcription factors Spdef,17,18 Sox9,39,40
Gﬁ1,19,41 and Creb3l142; transcription co-repressors
Cbfa2t2 and Cbfa2t343–46; and secretory lineage-speciﬁc
genes such as Best2, Spink4, Muc2, Sct, EphB3, Xbp1, and
Clca3.17,47–49 To gain broader insight into ATOH1 targetons in ileum and colon. (A) Genome distribution of ATOH1
, and H3K27me3 signals generated from ChIP-seq fragment
e ATOH1 binding sites were compared between ileum, colon,
t scores for the entire genome separated into 10-kb segments.
ts. (D) Comparison of enrichment scores in the regions with
ileum or colon. Black points indicate regions with signiﬁcant
nt peaks from the colon but not ileum, and blue points are
hIP-seq peaks according to the distance from TSS. (F) Genes
eﬁned as ATOH1-associated genes. Venn diagram indicates
Logos for the top motifs enriched in ATOH1-binding sites are
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Figure 4. Validation of




ATOH1 binds to the pro-
moter regions of Sox9,
Gﬁ1, and Spdef. The peak
density plots show frag-
ment counts across the
indicated genomic interval.
Sox9, Gﬁ1, and Spdef
genes are labeled in blue
with exons as thick rect-
angles (coding sequence is
slightly thicker) and introns
as lines connecting rect-
angles. The arrows show
primers designed for ChIP
PCR. The green rectangles
indicate regions selected
for ATOH1-Flag ChIP PCR.
(B) Ileal and colonic crypts
isolated from Atoh1Flag/Flag
mice were used to validate
ATOH1 ChIP-seq peaks by
ChIP PCR. ATOH1 was
enriched in all ATOH1
binding regions predicted
by our ATOH1 ChIP-seq,
but not the negative con-
































































































































1178genes in the intestines, we performed GO analysis using
DAVID. ATOH1 target genes were associated with ontology
terms including positive regulation of transcription ma-
chinery (adjusted P < .03), suggesting that ATOH1 is a
regulator of other transcriptional regulators, consistent with
a function as a master regulator of intestinal differentiation
(Figure 5B). In addition, ATOH1 target genes are mem-
bers of ontology groups such as intracellular transport,
guanosine triphosphatase regulator activity, Rab guanosineFLA 5.4.0 DTD  JCMGH172 proof  5triphosphatase binding, acetylgalactosaminyltransferase
activity, and positive regulation of metabolic process, and so
forth, indicating roles for ATOH1 in directing the program of
modiﬁcation and secretion of proteins from intestinal
secretory cells (Figure 5B, Supplementary Table 10). We
also found that ATOH1 targets were enriched in BMP
signaling pathway constituents, suggesting a previously
undeﬁned role for ATOH1 in intestinal BMP signaling




Figure 5. Direct ATOH1
transcriptional targets in
adult intestines. (A) Over-
lap of ATOH1-associated
genes from ChIP-seq and
genes signiﬁcantly enriched
in ATOH1-positive cells
from RNA-seq identiﬁes the
ATOH1 targetome, a list of
putative direct transcrip-
tional ATOH1 targets in the
ileum and colon. (B) GO
analysis using DAVID iden-
tiﬁed ontology terms asso-
ciated signiﬁcantly with












































































































































1296in the intestines, we next asked whether genes signiﬁcantly
de-enriched in ATOH1-positive cells (Figure 2F) also were
bound by ATOH1 (Figure 3F). Surprisingly, a large number
of genes, 1085 genes in the colon and 194 genes in the
ileum, were identiﬁed (Figure 5C, Supplementary Table 11).
Of note, among these genes, 2 important Notch pathway
genes, Notch receptor Notch1 and transcription factor Hes1,
were identiﬁed. Interestingly, we also found several genes
that previously have been described to be important for
Microfold cells and enterocytes, such as Spib, Elf3, andFLA 5.4.0 DTD  JCMGH172 proof  5Ppargc1b.50–52 In this scenario, one possibility is that
ATOH1 functions as a transcriptional activator of these
genes in a subset of ATOH1-positive cells, but other factors
repress their expression in the majority of cells, or drive
stronger expression in ATOH1-negative cells, resulting in
stronger relative expression in ATOH1-negative cells. How-
ever, we cannot exclude the possibility that ATOH1 func-
tions as a negative regulator of transcription of these genes.
GO analysis indicated that these de-enriched ATOH1 targets
were associated signiﬁcantly with several biologicalNovember 2016  7:29 pm  ce DVC
Figure 6. In situ validation of ATOH1 targe-
tome. Fresh-frozen ileal tissues were
generated from Atoh1 deletion (Fabp1Cre;
Atoh1lox/lox; knockout [KO]) or littermate
control (Fabp1Cre; Atoh1þ/þ; wild type [WT])
mice. The mRNA expression of ATOH1 target
genes, including (A) Nﬁa, (B) Hepacam2,
(C) Krt18, (D) Txndc11, (E) Atxn1, and
(F) Sh3bgrl3, were shown by in situ hybrid-
izations. Light periodic acid–Schiff staining
was performed after in situ hybridization
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1532processes including nucleotide binding, positive regulation
of cellular biosynthetic process, positive regulation of tran-
scription, actin cytoskeleton organization, guanosine tri-
phosphatase regulator activity, negative regulation of
transcription, and epithelium development (Figure 5D,
Supplementary Table 12). Taken together, these results
indicated that ATOH1 functions as a master transcription
factor, directly regulating the program of differentiation and
function within secretory cells in the intestines.
In Situ Validation of ATOH1 Targetome
Identiﬁes Novel Secretory Cell Markers
To validate the mRNA expression of the genes identiﬁed
in the ATOH1 targetome, we performed in situ hybridiza-
tions on the ileum of transgenic mice where ATOH1 is
deleted (Fabp1Cre; Atoh1lox/lox) and in littermate controls
(Fabp1Cre; Atoh1þ/þ).8 Six genes that have not been fully
studied in the intestinal secretory cells were selected
randomly from the list of ATOH1 targets (Supplementary
Table 9). These included the transcription factor nuclear
factor I/A (Nﬁa), HEPACAM family member 2 (Hepacam2),
keratin 18 (Krt18), thioredoxin domain-containing 11
(Txndc11), ataxin 1 (Atxn1), and SH3 domain binding
glutamate-rich protein–like 3 (Sh3bgrl3). We found that the
mRNA expression of Nﬁa is restricted in Paneth cells and
completely depleted in Atoh1 deletion tissues (Figure 6A). In
addition, we identiﬁed Hepacam2 as an ATOH1-dependent
goblet cell gene in the ileum (Figure 6B). Krt18 expression
is scattered in what appear to be progenitor cells in the
crypts and a minority of cells in the villus. In Atoh1 mutant
tissues, Krt18-positive cells in villus, but not in crypts, retain
the expression of Krt18, suggesting these Krt18-positive
cells in villus are not derived from ATOH1-positive
secretory lineage (Figure 6C). Finally, we found that
Txndc11, Atxn1, and Sh3bgrl3 are expressed not only in
goblet cells, Paneth cells, and transit amplifying cells, but
also in the other epithelial cell types (Figure 6D–F).
Although the mRNA level of these 3 genes are decreased in
Atoh1 mutant tissues, it is clear that they also are expressed
in some remaining cells through ATOH1-independent tran-
scription. Taken together, these results indicated that the
ATOH1 targetome we generated in this study is a valuable
resource for identifying novel secretory cell genes.
ATOH1 Transcriptional Targets in
Human Colorectal Cancer Cells
ATOH1 is highly conserved between species.53 In colo-
rectal cancers (CRCs), ATOH1 functions as a tumor sup-
pressor.54 Re-expression of ATOH1 in colon cancer cells not
only inhibits proliferation but also promotes apoptosis,
suggesting a potential window for new CRC therapeutics.
Therefore, identiﬁcation of ATOH1 targets in human CRCs
will provide novel insights into CRC therapeutics. We asked
whether ATOH1 shares similar transcriptional targets
between normal intestines and human CRC cells. First, we
focused on Cbfa2t3, a direct ATOH1 target that we identiﬁed
in mouse colon. CBFA2T3 (also referred to as MTG16 or
ETO2) is one of the MTG family of transcriptionalFLA 5.4.0 DTD  JCMGH172 proof  5corepressors that contributes to intestinal crypt prolifera-
tion and regeneration after injury.45,46 Our ATOH1 ChIP-seq
data indicated that ATOH1 strongly binds to the ﬁrst exon/
intron of Cbfa2t3 (Figure 7A). By using the UCSC Qgenome
browser (genome.ucsc.edu), we identiﬁed a corresponding
region within the human CBFA2T3 promoter that contained
several putative ATOH1 binding motifs (Figure 7A). To
determine whether ATOH1 binds to the CBFA2T3 promoter
in human CRC cells, we performed ChIP-PCR for transiently
expressed ATOH1-GFP in human colon cancer cell line
HCT116. Compared with mock-transfected cells, ATOH1 was
enriched in the promoter region of CBFA2T3, but not in the
downstream negative control region (Figure 7B). We
extended our analysis of potentially conserved ATOH1
targets by examining another 8 ATOH1 colonic target genes,
including HDAC1, RAPGEF3, SOX9, GFI1, SPDEF, MAML3, KIT,
and CREB3L1. By using a similar approach as described for
CBFA2T3 earlier, we identiﬁed orthologous human se-
quences with predicted ATOH1 binding sites for all 8 genes.
ChIP PCR conﬁrmed that ATOH1 bound to all 8 predicted
ATOH1 binding regions, but not in the negative control re-
gions, indicating strong conservation of ATOH1 binding sites
across species (Figure 7B). To further determine whether
ATOH1 could functionally regulate the expression of these
genes in human CRCs, we isolated ATOH1-positive cells by
ﬂow cytometry followed by reverse-transcription quantita-
tive PCR (RT-qPCR). Compared with ATOH1-negative cells,
the expression of CBFA2T3, SPDEF, RAPGEF3, and MAML3
were up-regulated signiﬁcantly in ATOH1-positive cells
(Figure 7C). In addition, the expression of GFI1 and KIT was
increased in ATOH1-positive cells. In contrast, ATOH1
induced a small but signiﬁcant decrease in HDAC1 expres-
sion (Figure 7C). Taken together, these results suggested
that ATOH1 functionally regulates the majority of these
genes not only in mouse colon, but also in human CRCs.SPDEF Cooperates With ATOH1 to
Amplify Target Gene Expression
We next sought to identify transcription factors that are
likely to co-regulate gene expression with ATOH1. Our
unbiased de novo motif analysis (Figure 3E) identiﬁed many
potential co-regulators, but most of these sites included
intergenic regions of unknown signiﬁcance. Therefore, we
performed a motif scan analysis of the colon-speciﬁc ATOH1
targetome. Speciﬁcally, HOMER was used to scan for 10-mer
motifs that were enriched signiﬁcantly in the ATOH1 tar-
getome while optimized for 50 motifs during the search
(ﬁndMotifsGenome.pl –len 10 –S 50). This analysis showed
SPDEF binding motifs enriched within the ATOH1 targetome
(Figure 8A), with SPDEF motifs associated with 75 of 658
(11%) of ATOH1 target genes in the colon (Supplementary
Table 13). Of note, among these genes we found several
goblet cell–associated genes, including Atoh1, Spdef, Muc2,
Reg4, Klk1, Creb3l1, and Slc12a8. Previous studies have
suggested that SPDEF plays a critical role in controlling
goblet cell terminal differentiation.17,18 To determine the
interdependence between ATOH1 and SPDEF to control
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Figure 7. (See previous page). ATOH1 transcriptional targets in human colorectal cancer cells. (A) Highly conserved promoter
sequence of Cbfa2t3 bound by ATOH1 between human and mouse genome. Several putative ATOH1 binding motifs
5’-CANNTG-3’ within the ATOH1 peak were highlighted (red). (B) Human colon cancer cell line HCT116 was transfected
transiently with ATOH1-GFP and used for ChIP PCR. Anti-GFP antibodies were used for ChIP. (C) Real-time PCR analysis of
complementary DNAs synthesized from mRNA isolated from FACS puriﬁed ATOH1-GFP–positive or ATOH1-GFP–negative
HCT116 cells 48 hours after transient transfection. Relative fold change is presented as means ± SEM of 3 independent












Figure 8. SPDEF functions as a transcriptional co-regulator of ATOH1. (A) Flow chart for identifying SPDEF binding motifs
within ATOH1 binding regions in the colon ATOH1 targetome. P values are for motif enrichment. (B) Real-time PCR analysis of
complementary DNAs synthesized from mRNA isolated from mouse colonic crypts. Spdef null or littermate wild-type control
mice were treated with either vehicle or dibenzazepine (DBZ) for 5 consecutive days. Relative fold change is presented as
means ± SEM (*P < .05, ** Q49P < .01, and ***P < .001). ANOVA, analysis of variance; TFs
Q50
, _______________.


































































































































































































































































Figure 10. Proposed model of transcriptional co-regulation
by ATOH1 and SPDEF.












































































































1994assessed the effect of overexpression of ATOH1 or SPDEF in
the absence of the other protein. We enhanced ATOH1
expression using the g-secretase inhibitor, DBZ, in wild-type
and Spdef null mice, and assessed target gene expression in
colonic crypts by RT-qPCR. As expected, DBZ treatment
increased the expression of Atoh1 and all downstream
target genes in wild-type mice (Figure 8B, open circles).
Deletion of Spdef signiﬁcantly blunted the effects of DBZ-
ATOH1–mediated transcription in a subset of ATOH1 target
genes, including Creb3l1, Slc12a8, Muc2, and Reg4, but not
others, such as Cbfa2t3 and Klk1 (Figure 8B, closed squares).
These results suggested that ATOH1 is sufﬁcient to drive
target gene expression and that as a direct target of ATOH1,
SPDEF provides positive feedback to amplify ATOH1-
dependent transcription of a subset of secretory
cell–associated genes, especially goblet cell genes.
To further establish the epistastic relationship between
ATOH1 and SPDEF, we asked whether SPDEF could activate
expression of secretory cell genes in the absence of ATOH1.
To test this hypothesis, transgenic mice in which ATOH1 is
deleted in the intestinal epithelium (Fabp1Cre; Atoh1lox/lox)
were bred with tetracycline-inducible SPDEF transgenic
mice (Rosa26LSL-rtta-ires-EGFP; TRE-Spdef). In this mouse
model, Fabp1-Cre is expressed in a patchy pattern in the
ileum and colon (Figure 9A).8 With the Rosa LSL-rtta-ires-EGFP
reporter, we were able to sort GFP-positive Atoh1
deletion cells from control (Fabp1Cre; Atoh1lox/lox;
Rosa26 LSL-rtta-ires-EGFP) and littermate (Fabp1Cre; Atoh1lox/lox;
Rosa26 LSL-rtta-ires-EGFP; TRE-Spdef) mice; we induced SPDEF
expression in Atoh1-mutant cells by treating these mice with
tetracycline in water for 5 consecutive days (Figure 9A).
Thus, after isolating 7AAD-negative (live) cells by ﬂow
cytometry from control or SPDEF-induced colonic crypts,
we were able to analyze the mRNA expression by RT-qPCR
of the following: (1) wild-type (GFP-negative cells from
either control or TRE-SPDEF mice), (2) Atoh1 deletion
(GFP-positive cells from control mice), and (3) Atoh1 dele-
tion and Spdef overexpression (GFP-positive cells from
TRE–SPDEF mice) cells (Figure 9A). As expected, in Atoh1
deletion (GFP-positive) cells, the mRNAs of ATOH1 targets
were decreased signiﬁcantly compared with wild-type (GFP-
negative) cells (Figure 9B, open triangles). In contrast,
despite robust transgene induction (w20-fold), SPDEF was
not sufﬁcient to activate transcription of Creb3l1, Slc12a8,
Muc2, Reg4, Cbfa2t3, and Klk1 in Atoh1 deletion cells
(Figure 9B). Taken together, these results indicated that
SPDEF ampliﬁes ATOH1-mediated transcription of secretory
cell genes, but is insufﬁcient to drive secretory cell gene
expression in the absence of ATOH1 (Figure 10).Figure 9. (See previous page). SPDEF functions as a transcrip
the inducible mouse model (Fabp1Cre; Atoh1lox/lox; Rosa26 L
transcription. Arrowheads indicate loxP sites. SPDEF expres
tetracycline (2 mg/mL). Fabp1-Cre is expressed in a patchy patt
GFP (Atoh1 deletion region) combined with Alcian blue staining
adjacent wild-type colonic epithelium. (B) GFP-positive cells w
PCR analysis. Relative fold change is presented as means ± S
of variance; KO, knockout; OE, _______________; WT, wild type
FLA 5.4.0 DTD  JCMGH172 proof  5Discussion
In this study, we used a combination of RNA-seq and
ChIP-seq techniques together with cell sorting and state-of-
the-art transgenic mice to identify more than 700 direct
transcriptional targets of ATOH1 in the small and large in-
testines. Of note, these unbiased genome-wide approaches
were performed in primary ileal and colonic crypts under
homeostatic conditions, thereby increasing the relevance
and credibility of identiﬁed target genes. Our data showed
that ATOH1 strongly binds to core promoter and enhancer
regions, which were marked by the active chromatin histone
modiﬁcation H3K27Ac, suggesting that ATOH1 likely func-
tions as a transcriptional activator. Although the physio-
logical function of ileum and colon are very different, the
ATOH1-associated genes were highly similar in these 2
tissues. The ontology analysis indicated that ATOH1 directly
regulates several important biological processes and
controls the transcription machinery of secretory lineage
differentiation, suggesting that ATOH1 is required for
specifying and maintaining secretory cells throughout the
intestinal epithelium.
The Notch signaling pathway is critical for gastrointes-
tinal cell fate determination.5,55,56 In the adult intestines,
activation of Notch signaling induces the expression of
HES1, which directly represses Atoh1, and thus directstional co-regulator of ATOH1. (A) Experimental strategy using
SL-rtta-ires-EGFP; TRE-Spdef). Arrows indicate the direction of
sion was induced by feeding mice with water containing
ern in the ileum and colon. Immunohistochemistry staining of
(for goblet cells) staining indicates the Atoh1 deletion and the
ere FACS-puriﬁed from colonic crypts followed by real-time
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2122progenitors to differentiate along the absorptive lineage. On
the other hand, adjacent progenitors that escape Notch
activation express ATOH1, which commits these cells to the
secretory lineage. Considerable genetic evidence suggests
that ATOH1 is a key transcription factor that controls Notch-
mediated lateral inhibition.16 However, the details under-
lying this mechanism are characterized incompletely.
Previous studies have suggested that DLL1 and DLL4 are
key Notch ligands required for maintaining ISC homeostasis
and differentiation.57 Simultaneous deletion of Dll1 and Dll4
phenocopies the loss of Notch activity and causes the
complete conversion of proliferating progenitors into post-
mitotic secretory cells, resulting in loss of the active ISC
population.57 In this study, we identiﬁed Dll1 and Dll4 as
direct targets of ATOH1, conﬁrming a central role for
ATOH1 in control of lateral inhibition from ATOH1-positive
secretory progenitors to adjacent absorptive progenitors/
stem cells. In addition to Dll1 and Dll4, several other Notch
signaling pathway components were identiﬁed as ATOH1-
associated genes, such as CSL transcriptional co-activator
Maml3 and Crebbp, CSL transcriptional co-repressor
Hdac1, Ncor2, Ctbp1 and Ctbp2, Notch ligand Jag1, Notch
receptor Notch1, and Notch antagonist Numb.58–63 Taken
together, our data suggest that ATOH1 functions as a master
transcription factor for Notch-mediated lateral inhibition by
directly activating Notch ligands to reinforce secretory cell
fate commitment. Expression of ATOH1 is likely to be the
key event in commitment of differentiating cells to the
secretory lineage.
ATOH1 is required for the differentiation of all intestinal
secretory cells.7 Consistent with these observations, the
expression of goblet cell–, Paneth cell–, and enteroendocrine
cell–speciﬁc genes were decreased after conditional deletion
of ATOH1 throughout the intestinal epithelium. Interest-
ingly, our immunoﬂuorescence staining suggested that
ATOH1 is expressed at much lower levels in enter-
oendocrine cells than in goblet and Paneth cells. This
observation can explain why we did not ﬁnd
enteroendocrine-speciﬁc genes in ATOH1-positive cells
puriﬁed from Atoh1GFP/GFP mice. The lower expression level
of ATOH1 in enteroendocrine cells may be caused by post-
translational modiﬁcation or by the other negative tran-
scriptional feedback. We speculate that different levels of
ATOH1 specify different subtypes of secretory cells, which
may contribute to secretory cell allocation.64
Several transcription factors downstream of ATOH1,
such as SPDEF and GFI1, were shown to regulate secretory
cell differentiation.17–19 However, little is known about how
these transcription factors modulate secretory gene
expression. Our data indicated that SPDEF ampliﬁes ATOH1-
dependent transcription of a subset of goblet cell genes
(Figure 8B). Although we cannot determine whether the
ampliﬁcation of ATOH1-dependent transcription is contrib-
uted directly by SPDEF binding to the chromatin or caused
indirectly by the other critical components lost in Spdef null
mice, de novo motif analysis indicated a signiﬁcant enrich-
ment of the SPDEF binding motif within the ATOH1 targe-
tome, suggesting the possibility that SPDEF coordinates
with ATOH1 on the promoter or enhancer regions of theseFLA 5.4.0 DTD  JCMGH172 proof  5genes (Figure 8A). We further found that SPDEF itself is not
sufﬁcient to activate ATOH1 targets, suggesting a hierarchy
of transcription factor–mediated gene expression during
intestinal cell differentiation (Figure 9B). One caveat of this
experiment was that Atoh1 deletion tissues lack speciﬁed
secretory cells, therefore the majority of these cells are
enterocytes. Thus, SPDEF might not be able to regulate
secretory gene transcription in the enterocyte context owing
to limited chromatin accessibility. However, our unpub-
lished data suggested that SPDEF is able to drive mucus-like
production in Atoh1 deletion tissues, indicating SPDEF
retains at least part of its biological function in enterocytes
(data not shown). Moreover, a previous study indicated that
secretory and absorptive progenitors show similar distri-
butions of histone marks and DNase hypersensitivity,
suggesting intestinal lineage determination is not dependent
on chromatin priming.16 Based on our ﬁndings in this and
previous studies, as a master transcription factor, it is most
likely that ATOH1 is expressed at the earliest step of
secretory progenitor differentiation, and it must be contin-
uously expressing in all secretory lineages for their main-
tenance. Within secretory progenitor cells, an unknown
mechanism results in NEUROG3 or GFI1 expression; those
cells that express GFI1 commit to the Paneth/goblet cell
fate; we suggest that ATOH1 expression levels may mediate
this decision. Subsequently, when SPDEF is activated in the
progenitors, it strengthens the expression of ATOH1-
dependent goblet genes, resulting in goblet cell terminal
differentiation. We suggest that in addition to ATOH1-
dependent targets, SPDEF also may regulate transcription
of ATOH1-independent goblet gene expression (Figure 10).
Future studies to determine how transcription networks
select alternate secretory cell fates will expand our current
knowledge of stem cell biology and chromatin biology of the
intestinal cells.
Previous studies have suggested that ATOH1 functions
as a tumor suppressor in human CRCs.54 To gain more
insight into this activity, we examined whether ATOH1
shares similar transcriptional targets in mouse colonic
crypts and human colon cancer cell line HCT116. Interest-
ingly, even though ATOH1 binds to all of the human ATOH1
targets predicted by our murine ChIP-seq analysis, only 4 of
9 of these ATOH1 targets were regulated in a similar
manner at the transcriptional level. Because canonical
Wnt/b-catenin signaling is hyperactivated in HCT116 owing
to a gain-of-function b-catenin mutation, it is possible that
this interferes with ATOH1 target gene expression in colon
cancer cells. It also is possible that Wnt/b-catenin target
genes, such as SOX9, are expressed at maximal levels in CRC
cells and further transcriptional activation by ATOH1 is not
possible.65 Alternatively, the transcriptional machinery of
ATOH1 might rely on different cofactors that are not avail-
able in these cancer cells. These data highlight the difﬁculty
of using cancer cell lines to extrapolate information about
transcriptional targets in normal tissues.
We previously identiﬁed SPDEF as a tumor suppressor in
both murine and cell culture CRC models.66 Consistent with
these observations, in this study, we show that ATOH1 binds
to SPDEF and directly regulates its expression in bothNovember 2016  7:29 pm  ce DVC


































































































2220mouse intestines and human colon cancer cells. Given pre-
vious ﬁndings that ATOH1 is a colorectal tumor suppres-
sor,13,54,67 our study suggests that SPDEF may be a key
mediator of ATOH1’s tumor-suppressive activity. Further
studies of direct transcriptional targets of ATOH1, such as
SPDEF, in human CRCs will provide insight into therapeutic
strategies for targeting human CRCs through the
Notch–ATOH1 axis.
Next-generation sequencing provides unbiased genome-
wide approaches to studying transcriptional machinery.
However, there are some caveats to this study. First,
although we performed the ATOH1 ChIP-seq in puriﬁed
intestinal crypts, these data derive from a mixed cell popu-
lation. Thus, we cannot distinguish whether ATOH1 binding
sites were present in all ATOH1-positive cells or are found
only in a subpopulation. Second, ChIP-seq cannot identify
binding sites in relatively rare subpopulations of cells
(eg, enteroendocrine cells), and therefore these may be
missed in this study. We noted that the ATOH1 ChIP-seq
from colonic crypts identiﬁed more binding sites than from
ileal crypts. This is possibly owing to the gradient of
endogenous ATOH1 expression in the adult intestine—much
higher in the colon than ileum. Advanced ChIP-seq and RNA-
seq techniques for small amounts of sorted cells will be
helpful to address these caveats in the future. Further inte-
gration of the ATOH1 transcriptional network with other
pathways regulating intestinal differentiation and homeo-
stasis is an important future direction for this project.68–70
In summary, this study unveiled the direct targets of
ATOH1 in the adult intestine, providing novel insight toward
understanding the cell differentiation and biological func-
tion of intestinal secretory lineages. We further showed
interaction between ATOH1 and SPDEF to regulate the
expression of a subset of target genes, suggesting that basal
expression of secretory cell genes may require ampliﬁcation
factors to achieve full expression. Thus, our results identify
novel interactions between secretory lineage-speciﬁc tran-
scription factors that control cellular differentiation and
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